Notably, mutations in TBK1, CYLD, and OPTN have been identified in both ALS and FTD, supporting the idea that these disorders are two different manifestations of a single clinicopathological spectrum7,11–15. This evidence concerns the gene OPTN and amyotrophic lateral sclerosis.